Human monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial
Characterisation of a novel Respiratory Syncytial Virus (RSV) immune evasion mechanism and evaluation of the impact for development of novel vaccines and prophylactic and/or therapeutic antibodies
Protection against influenza A virus infection and modulation of antigen presentation by matrix protein 2-specific antibodies.
Dissecting the immunological and molecular mechanisms of gain-of-function NOD2 mutations in Blau Syndrome and Early Onset Sarcoidosis.
HIV-1 candidate vaccines can induce antibodies which share specificity with human monoclonal antibodies capable of neutralizing primary isolates
Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques